Generic Drug Companies Discussed in New Research Report Recently Published at MarketPublishers.com

13 Dec 2011 • by Natalie Aster
Generic Drug Companies Discussed in New Research Report Recently Published at MarketPublishers.com

LONDON – In common with a host of various markets worldwide, the generic and branded sectors also experience hard times amid today’s economic turmoil.

The generic industry was once considered as a valuable way to bring effective products within the reach of wider audience. This, tightly bound to the soaring prices for new advanced branded products, contributed to the sector’s rapid expansion. Even markets traditionally based in the provision of branded medicines have increasingly started prescribing generic drugs. But downward pressure on generic prices and, consequently, lower margins are creating pain for generic companies.

New research report Generic Drugs: Global Collaboration Opportunities” elaborated by Espicom Business Intelligence provides true and unprejudiced insights into the world’s leading generic drug companies, covering background information, products, major developments, and contact details.

Report Details:

Title: Generic Drugs: Global Collaboration Opportunities
Published: December, 2011
Pages: 410
Price: US$ 1,040

Report Contents:

INTRODUCTION
Companies in this report
Company Details in Focus

ARGENTINA
LABORATORIOS PHOENIX
Snapshot
Background
Products
Major Developments
Contact Details

AUSTRALIA
ALCHEMIA
Snapshot
Background
Products
Financials
Major Developments
Contact Details

ASCENT PHARMAHEALTH
Snapshot
Background
Products
Financials
Major Developments
Contact Details

BANGLADESH
BEXIMCO PHARMACEUTICALS
Snapshot
Background
Products
Financials
Major Developments
Contact Details

BRAZIL
HYPERMARCAS
Snapshot
Background
Products
Financials
Major Developments
Contact Details

LAFEPE
Snapshot
Background
Products
Major Developments
Contact Details

MOKSHA8
Snapshot
Background
Products
Major Developments
Contact Details

CANADA
AA PHARMA
Snapshot
Background
Products
Contact Details

BIOVECTRA
Snapshot
Background
Products
Major Developments
Contact Details

INTELLIPHARMACEUTICS
Snapshot
Background
Products
Financials
Major Developments
Contact Details

CHINA
AOXING PHARMACEUTICAL
Snapshot
Background
Products
Financials
Major Developments
Contact Details

CHINA PHARMA HOLDINGS
Snapshot
Background
Products
Financials
Contact Details

LAIYANG JIANGBO PHARMACEUTICALS
Snapshot
Background
Products
Financials
Major Developments
Contact Details

RXMIDAS PHARMACEUTICALS
Snapshot
Background
Products
Financials
Major Developments
Contact Details

ZHEJIANG HUAHAI PHARMACEUTICALS
Snapshot
Background
Products
Contact Details

EGYPT

EIPICO
Snapshot
Background
Products
Contact Details

FRANCE
BIOALLIANCE PHARMA
Snapshot
Background
Products
Financials
Major Developments
Contact Details

GERMANY
ALFRED E TIEFENBACHER (AET)
Snapshot
Background
Products
Contact Details

GREECE
GENEPHARM
Snapshot
Background
Products
Contact Details

PHARMATHEN
Snapshot
Background
Products
Financials

More new research reports by the publisher can be found at Espicom Business Intelligence page.

 

CONTACTS

The Market Publishers, Ltd.

Tanya Rezler

Tel: +44 208 144 6009

Fax: +44 207 900 3970

ps@marketpublishers.com

MarketPublishers.com